• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Alport 综合征。

Alport Syndrome.

机构信息

Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.

Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, University of Miami Ear Institute, Miami, FL.

出版信息

Adv Kidney Dis Health. 2024 May;31(3):170-179. doi: 10.1053/j.akdh.2024.02.004.

DOI:10.1053/j.akdh.2024.02.004
PMID:39004457
Abstract

Alport syndrome (AS) is characterized by progressive kidney failure, hematuria, sensorineural hearing loss, and ocular abnormalities. Pathogenic variants in the COL4A3-5 genes result in a defective deposition of the collagen IV α3α4α5 protomers in the basement membranes of the glomerulus in the kidney, the cochlea in the ear and the cornea, lens capsule and retina in the eye. The presence of a large variety of COL4A3-5 gene(s) pathogenetic variants irrespective of the mode of inheritance (X-linked, autosomal recessive, autosomal dominant, or digenic) with and without syndromic features is better defined as the "Alport spectrum disorder", and represents the most common cause of genetic kidney disease and the second most common cause of genetic kidney failure. The clinical course and prognosis of individuals with AS is highly variable. It is influenced by gender, mode of inheritance, affected gene(s), type of genetic mutation, and genetic modifiers. This review article will discuss the epidemiology, classification, pathogenesis, diagnosis, clinical course with genotype-phenotype correlations, and current and upcoming treatment of patients with AS. It will also review current recommendations with respect to when to evaluate for hearing loss or ophthalmologic abnormalities.

摘要

Alport 综合征(AS)的特征是进行性肾衰竭、血尿、感觉神经性听力损失和眼部异常。COL4A3-5 基因的致病性变异导致肾脏肾小球基底膜、耳朵耳蜗和角膜、晶状体囊和视网膜中胶原 IV α3α4α5 三聚体的沉积缺陷。存在大量不同的 COL4A3-5 基因突变(无论遗传方式(X 连锁、常染色体隐性、常染色体显性或双基因)如何)伴有或不伴有综合征特征,更好地定义为“Alport 谱障碍”,是遗传性肾脏疾病最常见的原因,也是遗传性肾衰竭的第二大常见原因。AS 个体的临床病程和预后高度可变。它受性别、遗传方式、受影响的基因、基因突变类型和遗传修饰剂的影响。本文综述了 AS 的流行病学、分类、发病机制、诊断、与基因型-表型相关性的临床病程以及当前和未来的治疗方法。还回顾了关于何时评估听力损失或眼科异常的当前建议。

相似文献

1
Alport Syndrome.Alport 综合征。
Adv Kidney Dis Health. 2024 May;31(3):170-179. doi: 10.1053/j.akdh.2024.02.004.
2
Alport Syndrome: Achieving Early Diagnosis and Treatment.阿尔波特综合征:实现早期诊断和治疗。
Am J Kidney Dis. 2021 Feb;77(2):272-279. doi: 10.1053/j.ajkd.2020.03.026. Epub 2020 Jul 22.
3
Ocular features in Alport syndrome: pathogenesis and clinical significance.阿尔波特综合征的眼部特征:发病机制及临床意义
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):703-9. doi: 10.2215/CJN.10581014. Epub 2015 Feb 3.
4
Pseudodominant Alport syndrome caused by pathogenic homozygous and compound heterozygous COL4A3 splicing variants.由致病性同源和复合杂合 COL4A3 剪接变异引起的假显性 Alport 综合征。
Ann Hum Genet. 2022 May;86(3):145-152. doi: 10.1111/ahg.12454. Epub 2021 Dec 9.
5
Familial hematuria: A review.家族性血尿:综述
Medicina (Kaunas). 2017;53(1):1-10. doi: 10.1016/j.medici.2017.01.002. Epub 2017 Jan 31.
6
Digenic Alport Syndrome.双基因 Alport 综合征。
Clin J Am Soc Nephrol. 2022 Nov;17(11):1697-1706. doi: 10.2215/CJN.03120322. Epub 2022 Jun 8.
7
Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.常染色体显性遗传性阿尔波特综合征的临床及遗传特征:一项队列研究
Am J Kidney Dis. 2021 Oct;78(4):560-570.e1. doi: 10.1053/j.ajkd.2021.02.326. Epub 2021 Apr 7.
8
Guidelines for Genetic Testing and Management of Alport Syndrome.《Alport 综合征的基因检测与管理指南》。
Clin J Am Soc Nephrol. 2022 Jan;17(1):143-154. doi: 10.2215/CJN.04230321. Epub 2021 Dec 20.
9
Renal, auricular, and ocular outcomes of Alport syndrome and their current management.Alport 综合征的肾脏、耳部和眼部结局及其当前的治疗方法。
Pediatr Nephrol. 2018 Aug;33(8):1309-1316. doi: 10.1007/s00467-017-3784-3. Epub 2017 Sep 1.
10
Endothelial cell-specific collagen type IV-α expression does not rescue Alport syndrome in Col4a3 mice.内皮细胞特异性IV型胶原蛋白α表达不能挽救Col4a3小鼠的奥尔波特综合征。
Am J Physiol Renal Physiol. 2019 May 1;316(5):F830-F837. doi: 10.1152/ajprenal.00556.2018. Epub 2019 Feb 6.

引用本文的文献

1
Collagen IV in Gould syndrome and Alport syndrome.古尔德综合征和奥尔波特综合征中的IV型胶原蛋白。
Nat Rev Nephrol. 2025 Jul 31. doi: 10.1038/s41581-025-00982-x.
2
-p.Gly624Asp is the Predominant Variant in Europe Associated With a Mild Alport Syndrome Phenotype.-p.Gly624Asp是欧洲与轻度奥尔波特综合征表型相关的主要变异体。
Kidney Int Rep. 2025 Mar 6;10(5):1372-1383. doi: 10.1016/j.ekir.2025.02.031. eCollection 2025 May.
3
Proteinuria in Alport Syndrome: Treatment With Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors.Alport综合征中的蛋白尿:使用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂进行治疗
Cureus. 2025 May 4;17(5):e83455. doi: 10.7759/cureus.83455. eCollection 2025 May.
4
The Role of Vitamin D in Rare Diseases-A Clinical Review.维生素D在罕见病中的作用——一项临床综述
Biomedicines. 2025 Feb 22;13(3):558. doi: 10.3390/biomedicines13030558.